Jeffrey L. Probstfield

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann et al. · New England Journal of Medicine · 2014 · 2.6K citations · Full text

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Marc A. Pfeffer, Brian Claggett, Rafael Díaz et al. · New England Journal of Medicine · 2015 · 2.3K citations · Full text

Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

Marshall B. Elam, Henry N. Ginsberg, Laura Lovato et al. · JAMA Cardiology · 2016 · 185 citations · Full text

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Marc A. Pfeffer, Brian Claggett, Rafael Díaz et al. · New England Journal of Medicine · 2015 · 131 citations

Glucagon-like Peptide 1–Receptor, Metabolic Syndrome, Diabetes Management +13

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Rhonda Bentley–Lewis, David Aguilar, Matthew C. Riddle et al. · American Heart Journal · 2015 · 96 citations

Thrombosis, Cardiovascular Disease, Lixisenatide Versus Placebo +11